Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

There have been millions invested in healthcare technology over the past 10 years focused primarily on improving the administrative efficiency of our healthcare system and providing greater access and coverage. Today, as the he...

View Blog Post
Blog Post

The appropriateness and safety of pain relievers are an issue of great concern for all prescribers, including dental professionals. A study published in 2017 sought to determine current evidence on postoperative strategies to r...

View Blog Post
Blog Post

The Centers for Disease Control and Prevention (CDC) recently recognized its annual World Tuberculosis (TB) Day on March 24. It is a time to reinforce the global healthcare community’s commitment to ending the spread of the b...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up